Wells Fargo & Company MN increased its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 11.0% in the 4th quarter, Holdings Channel reports. The firm owned 1,138,161 shares of the medical instruments supplier’s stock after acquiring an additional 112,928 shares during the quarter. Wells Fargo & Company MN’s holdings in AngioDynamics were worth $18,928,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. SG Americas Securities LLC acquired a new position in AngioDynamics during the third quarter worth approximately $143,000. Crossmark Global Holdings Inc. acquired a new position in AngioDynamics during the fourth quarter worth approximately $172,000. Trexquant Investment LP acquired a new position in AngioDynamics during the third quarter worth approximately $175,000. Teacher Retirement System of Texas acquired a new position in AngioDynamics during the fourth quarter worth approximately $201,000. Finally, Texas Yale Capital Corp. acquired a new position in AngioDynamics during the fourth quarter worth approximately $334,000. 95.62% of the stock is currently owned by institutional investors.
Several research analysts have commented on ANGO shares. TheStreet lowered AngioDynamics from a “b-” rating to a “c” rating in a research report on Tuesday, January 2nd. Craig Hallum lowered AngioDynamics from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. BidaskClub lowered AngioDynamics from a “hold” rating to a “sell” rating in a research report on Saturday, January 6th. Finally, Zacks Investment Research raised AngioDynamics from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a research report on Monday, January 8th. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $18.60.
AngioDynamics (NASDAQ:ANGO) last released its earnings results on Thursday, January 4th. The medical instruments supplier reported $0.16 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.16. The business had revenue of $86.70 million for the quarter, compared to analyst estimates of $88.15 million. AngioDynamics had a positive return on equity of 4.63% and a negative net margin of 2.27%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.19 earnings per share. equities analysts expect that AngioDynamics, Inc. will post 0.72 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “AngioDynamics, Inc. (ANGO) Position Raised by Wells Fargo & Company MN” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3255122/angiodynamics-inc-ango-position-raised-by-wells-fargo-company-mn.html.
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.